A sulfonated cartilage interpenetrating polymer network reinforces and protects the extracellular matrix of degraded cartilage
Source abstract
Abstract
Cartilage extracellular matrix (ECM) comprises a type-II collagen fibril network that affords structure and tensile strength, complemented by a negatively charged, sulfated glycosaminoglycan (GAG) matrix that retains interstitial water. These components act synergistically, bestowing the rheological and tribological material properties essential to cartilage function. At the onset of osteoarthritis, a disease characterized by cartilage degeneration, GAGs diminish from the ECM reducing interstitial fluid load support (IFLS), equilibrium stiffness, and transferring load to the collagen fibril network, which subsequently breaks down, culminating in increased hydraulic permeability, and decreased cartilage stiffness. We restore the material properties of damaged cartilage critical to diarthrodial joint function by forming an interpenetrating polymer network (IPN) with the native collagen using a synthetic, hydrophilic, and biocompatible GAG-mimetic polymer. Upon visible light activation, the monomer, 3-sulfopropylmethacrylate (SPM), and the crosslinker, polyethylene glycol diacrylate (PEGDA), form a sulfonated and anionic IPN that fills the existing porous collagen matrix of degraded cartilage. Mechanistically, the highly sulfonated, anionic SPM IPN retards water transport, reestablishes collagen fibril network integrity, and restores tissue equilibrium stiffness, thereby returning the stiffness and viscoelastic properties of degraded cartilage to levels near healthy cartilage. Additionally, the SPM IPN protects cartilage by reducing the infiltration of inflammatory cytokines that are known to upregulate catabolic matrix metalloproteinases and downregulate GAG production. STATEMENT OF SIGNIFICANCE: Amelioration of OA requires a comprehensive approach: neutralize or impede catabolic enzymes that degrade cartilage and reconstitute damaged cartilage by augmenting tissue ECM constituents. Currently, there are no clinical treatments that restore the viscoelastic material properties of hyaline cartilage tissue critical to its mechanical function and impart chondroprotection after OA induction. This work suggests that reconstituting GAG-depleted cartilage using a synthetic sulfonated interpenetrating polymer to reestablish IFLS instilled into the joint and polymerized with white light during conventional arthroscopy represents an effective, and minimally invasive strategy to restore the material properties of cartilage in the early stages of OA.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Osteoarthritis Treatment and Mechanisms · Total Knee Arthroplasty Outcomes · Hydrogels: synthesis, properties, applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (83)
Show source-provided references
1. Articular cartilage: from formation to tissue engineering10.1039/C6BM00068A ↗
2. Cartilage proteoglycans: structure and potential functions10.1002/jemt.1070280505 ↗
3. Cartilage interstitial fluid load support in unconfined compression10.1016/S0021-9290(03)00231-8 ↗
4. The permeability of articular cartilage under compressive strain and at high pressures10.2106/00004623-197658040-00014 ↗
5. Rolling resistance of articular cartilage due to interstitial fluid flow10.1243/0954411971534548 ↗
6. Lubrication of synovial membrane10.1136/ard.30.3.322 ↗
7. The frictional properties of animal joints10.1016/0043-1648(62)90176-X ↗
8. Experimental verification of the role of interstitial fluid pressurization in cartilage lubrication10.1016/j.orthres.2003.07.002 ↗
9. The role of interstitial fluid pressurization and surface porosities on the boundary friction of articular cartilage10.1115/1.2834416 ↗
10. The role of interstitial fluid pressurization in articular cartilage lubrication10.1016/j.jbiomech.2009.04.040 ↗
11. Molecular transport in articular cartilage - what have we learned from the past 50 years?10.1038/s41584-018-0033-5 ↗
12. The exclusion of large solutes by cartilage proteinpolysaccharide10.1002/bip.1964.360020307 ↗
13. Prevalence trends of site-specific osteoarthritis from 1990 to 2019: findings from the global burden of disease study 201910.1002/art.42089 ↗
14. Cartilage glycosaminoglycan loss in the acute phase after an anterior cruciate ligament injury: delayed gadolinium-enhanced magnetic resonance imaging of cartilage and synovial fluid analysis10.1002/art.20795 ↗
15. Early changes in material properties of rabbit articular cartilage after meniscectomy10.1002/jor.1100010102 ↗
16. Biochemical changes in the cartilage of the knee in experimental and natural osteoarthritis in the dog10.1302/0301-620X.58B1.131804 ↗
17. Long-distance running causes site-dependent decrease of cartilage glycosaminoglycan content in the knee joints of beagle dogs10.1002/art.1780361018 ↗
18. Early detection of aging cartilage and osteoarthritis in mice and patient samples using atomic force microscopy10.1038/nnano.2008.410 ↗
19. Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration10.1053/joca.1998.0170 ↗
20. Softening of the lateral condyle articular cartilage in the canine knee joint after long distance (up to 40 km/day) running training lasting one year10.1055/s-2007-1021056 ↗
21. Collagen type II C-telopeptide fragments as an index of cartilage degradation10.1016/S8756-3282(01)00504-X ↗
22. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage10.1136/ard.60.6.619 ↗
23. Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint10.1093/rheumatology/37.1.46 ↗
24. Metabolism of human femoral head cartilage in osteoarthrosis and subcapital fracture10.1136/ard.40.1.18 ↗
25. Acid hydrolase activity in osteoarthritic and normal human cartilage10.2106/00004623-197355050-00017 ↗
26. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H ↗
27. Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis10.1002/art.22174 ↗
28. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Quantitative analysis and effect of intraarticular corticosteroids10.1002/art.1780340905 ↗
29. Identification and concentration of the glycosaminoglycans of human articular cartilage in relation to age and osteoarthritis10.1007/BF02012552 ↗
30. Role of proteoglycans in osteoarthritis
31. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis10.1155/2014/561459 ↗
32. The role of inflammation in the pathogenesis of osteoarthritis10.1155/2020/8293921 ↗
33. Role of inflammation and the immune system in the progression of osteoarthritis10.1002/jor.24457 ↗
34. Cartilage interstitial fluid load support in unconfined compression following enzymatic digestion10.1115/1.1824123 ↗
35. Effect of proteoglycan removal on solute mobility in articular cartilage10.1016/S0021-9290(97)00059-6 ↗
36. Biomaterials for articular cartilage tissue engineering: learning from biology10.1016/j.actbio.2017.11.021 ↗
37. Recent progress in cartilage tissue engineering10.1016/j.copbio.2011.04.003 ↗
38. Cartilage tissue engineering: its potential and uses10.1097/01.bor.0000198005.88568.df ↗
39. Cartilage tissue engineering for degenerative joint disease10.1016/j.addr.2006.01.012 ↗
40. Recent advancements in cartilage tissue engineering innovation and translation10.1038/s41584-024-01118-4 ↗
41. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel10.1089/107632703768247377 ↗
42. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels10.1002/jbm.1217 ↗
43. Biological evaluation of polyvinyl alcohol hydrogel crosslinked by polyurethane chain for cartilage tissue engineering in rabbit model10.1007/s10856-013-4995-1 ↗
44. Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber size10.1089/ten.2006.12.1775 ↗
45. Articular cartilage repair using allogeneic perichondrocyte-seeded biodegradable porous polylactic acid (PLA): a tissue-engineering study10.1002/jbm.820290915 ↗
46. Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid10.1016/j.biomaterials.2011.08.073 ↗
47. Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis10.1089/ten.tea.2008.0067 ↗
48. Application of alginate hydrogels for next-generation articular cartilage regeneration10.3390/ijms23031147 ↗
49. A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology10.1016/j.biomaterials.2011.06.018 ↗
50. High seeding density of human chondrocytes in agarose produces tissue-engineered cartilage approaching native mechanical and biochemical properties10.1016/j.jbiomech.2016.04.039 ↗
51. Functional tissue engineering of articular cartilage through dynamic loading of chondrocyte-seeded agarose gels10.1115/1.429656 ↗
52. Interpenetrating polymer network hydrogels as bioactive scaffolds for tissue engineering10.1515/revce-2020-0039 ↗
53. Super tough double network hydrogels and their application as biomaterials10.1016/j.polymer.2012.03.013 ↗
54. Interpenetrating polymer network scaffold of sodium hyaluronate and sodium alginate combined with berberine for osteochondral defect regeneration10.1016/j.msec.2018.05.034 ↗
55. Nanocellulose-based interpenetrating polymer network (IPN) hydrogels for cartilage applications10.1021/acs.biomac.6b01243 ↗
56. Functional effects of an interpenetrating polymer network on articular cartilage mechanical properties10.1016/j.joca.2018.01.001 ↗
57. Reinforcement of articular cartilage with a tissue-interpenetrating polymer network reduces friction and modulates interstitial fluid load support10.1016/j.joca.2017.03.001 ↗
58. A tissue-penetrating double network restores the mechanical properties of degenerated articular cartilage10.1002/anie.201511767 ↗
59. Experimental and clinical evaluation of a new synthetic, absorbable sealant to reduce air leaks in thoracic operations10.1016/S0022-5223(99)70296-5 ↗
60. Randomized controlled trial of a synthetic sealant for preventing alveolar air leaks after lobectomy10.1016/S0003-4975(01)02468-7 ↗
61. Trial of a novel synthetic sealant in preventing air leaks after lung resection10.1016/S0003-4975(01)02537-1 ↗
62. Frictional response of bovine articular cartilage under creep loading following proteoglycan digestion with chondroitinase ABC10.1115/1.2133764 ↗
63. Elastic, viscoelastic and fibril-reinforced poroelastic material properties of healthy and osteoarthritic human tibial cartilage10.1007/s10439-019-02213-4 ↗
64. Cartilage stress-relaxation is affected by both the charge concentration and valence of solution cations10.1016/j.joca.2008.09.011 ↗
65. Viscoelasticity of the articular cartilage surface in early osteoarthritis10.1016/j.joca.2012.01.011 ↗
66. Raman spectroscopic probe provides optical biomarkers of cartilage composition predictive of tissue function10.1016/j.joca.2024.12.008 ↗
67. Raman needle arthroscopy for in vivo molecular assessment of cartilage10.1002/jor.25155 ↗
68. Raman spectroscopy-based water content is a negative predictor of articular human cartilage mechanical function10.1016/j.joca.2018.10.003 ↗
69. Interspecies comparisons of in situ intrinsic mechanical properties of distal femoral cartilage10.1002/jor.1100090304 ↗
70. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression10.1002/art.1780390914 ↗
71. The role of cytokines in osteoarthritis pathophysiology
72. A roadmap to target interleukin-6 in osteoarthritis10.1093/rheumatology/keaa248 ↗
73. Synthesis and characterization of proteoglycan-mimetic graft copolymers with tunable glycosaminoglycan density10.1021/bm501045k ↗
74. Biomimetic proteoglycans strengthen the pericellular matrix of normal and osteoarthritic human cartilage10.1021/acsbiomaterials.4c00813 ↗
75. Biomimetic molecules lower catabolic expression and prevent chondroitin sulfate degradation in an osteoarthritic ex vivo model10.1021/acsbiomaterials.5b00458 ↗
76. Synthesis and characterization of an aggrecan mimic10.1016/j.actbio.2011.12.029 ↗
77. Gelatin scaffolds containing partially sulfated cellulose promote mesenchymal stem cell chondrogenesis10.1089/ten.tea.2016.0461 ↗
78. Visible light initiating systems for photopolymerization: status, development and challenges10.1039/C4PY00072B ↗
79. The effect of polymer size and charge of molecules on permeation through synovial membrane and accumulation in hyaline articular cartilage10.1016/j.ejpb.2016.02.004 ↗
80. A triphasic theory for the swelling and deformation behaviors of articular cartilage10.1115/1.2894880 ↗
81. Contribution of proteoglycan osmotic swelling pressure to the compressive properties of articular cartilage10.1016/j.bpj.2011.07.006 ↗
82. Measurement of swelling pressure in cartilage and comparison with the osmotic pressure of constituent proteoglycans
83. Electrostatic and non-electrostatic contributions of proteoglycans to the compressive equilibrium modulus of bovine articular cartilage10.1016/j.jbiomech.2010.01.021 ↗